Stay updated on ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Sign up to get notified when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.

Latest updates to the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new Revision: v3.3.2 was added to the Record History and the previous Revision: v3.2.0 was removed.SummaryDifference0.1%

- Check20 days agoChange DetectedDeleted a notice about a lapse in government funding and potential processing delays, including references to cc.nih.gov and opm.gov for operating updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check34 days agoChange DetectedThe two screenshots show the same version history entries with no substantive updates to study data or status; any difference appears cosmetic. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedMajor update to operating-status notice and versioning (v3.2.0) with a new date window; older status and revision were removed.SummaryDifference14%

- Check70 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.3%

- Check84 days agoChange DetectedThe page revision updated from v3.0.1 to v3.0.2. The Back to Top element was removed.SummaryDifference0.8%

Stay in the know with updates to ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.